517 related articles for article (PubMed ID: 25472648)
1. Predictive Ability of Blood Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Gastrointestinal Stromal Tumors.
Racz JM; Cleghorn MC; Jimenez MC; Atenafu EG; Jackson TD; Okrainec A; Venkat Raghavan L; Quereshy FA
Ann Surg Oncol; 2015 Jul; 22(7):2343-50. PubMed ID: 25472648
[TBL] [Abstract][Full Text] [Related]
2. Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer.
Choi WJ; Cleghorn MC; Jiang H; Jackson TD; Okrainec A; Quereshy FA
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S603-13. PubMed ID: 25900206
[TBL] [Abstract][Full Text] [Related]
3. Blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are independent prognostic factors for surgically resected gastrointestinal stromal tumors.
Goh BK; Chok AY; Allen JC; Quek R; Teo MC; Chow PK; Chung AY; Ong HS; Wong WK
Surgery; 2016 Apr; 159(4):1146-56. PubMed ID: 26688506
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil-lymphocyte and platelet-lymphocyte ratio in patients after resection for hepato-pancreatico-biliary malignancies.
Spolverato G; Maqsood H; Kim Y; Margonis G; Luo T; Ejaz A; Pawlik TM
J Surg Oncol; 2015 Jun; 111(7):868-74. PubMed ID: 25865111
[TBL] [Abstract][Full Text] [Related]
5. [Associations of Preoperative Platelet-to-lymphocyte Ratio and Derived Neutrophil-to-lymphocyte Ratio with thePrognosis of Gastrointestinal Stromal Tumor].
Yin XN; Tang SM; Yin Y; Shen CY; Zhang B; Chen ZX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 48(2):239-243. PubMed ID: 28612534
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of survival and metastasis for recurrent hepatocellular carcinoma after transarterial chemoembolization.
Fan W; Zhang Y; Wang Y; Yao X; Yang J; Li J
PLoS One; 2015; 10(3):e0119312. PubMed ID: 25742141
[TBL] [Abstract][Full Text] [Related]
7. Blood neutrophil-to-lymphocyte ratio is prognostic in gastrointestinal stromal tumor.
Perez DR; Baser RE; Cavnar MJ; Balachandran VP; Antonescu CR; Tap WD; Strong VE; Brennan MF; Coit DG; Singer S; Dematteo RP
Ann Surg Oncol; 2013 Feb; 20(2):593-9. PubMed ID: 23054118
[TBL] [Abstract][Full Text] [Related]
8. Elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis of patients with primary gastrointestinal stromal tumor.
Chang WL; Yang WC; Zeng XY; Li CG; Xiong Z; Wang T; Zhang RZ; Tao KX; Zhang P
BMC Gastroenterol; 2020 Apr; 20(1):124. PubMed ID: 32321434
[TBL] [Abstract][Full Text] [Related]
9. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?
Ulas A; Avci N; Kos T; Cubukcu E; Olmez OF; Bulut N; Degirmenci M
J BUON; 2015; 20(3):714-22. PubMed ID: 26214622
[TBL] [Abstract][Full Text] [Related]
10. Postoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes of hepatocellular carcinoma.
Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ
J Surg Res; 2015 Sep; 198(1):73-9. PubMed ID: 26022997
[TBL] [Abstract][Full Text] [Related]
11. Preoperative monocyte-to-lymphocyte ratio predicts recurrence in gastrointestinal stromal tumors.
Cananzi FCM; Minerva EM; Samà L; Ruspi L; Sicoli F; Conti L; Fumagalli Romario U; Quagliuolo VL
J Surg Oncol; 2019 Jan; 119(1):12-20. PubMed ID: 30426498
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil-to-lymphocyte ratio: could it be used in the clinic as prognostic marker for gastrointestinal stromal tumor?
Atila K; Arslan NC; Derici S; Canda AE; Sagol O; Oztop I; Bora S
Hepatogastroenterology; 2014 Sep; 61(134):1649-53. PubMed ID: 25436357
[TBL] [Abstract][Full Text] [Related]
13. The Platelet-to-Lymphocyte Ratio Versus Neutrophil-to-Lymphocyte Ratio: Which is Better as a Prognostic Factor in Gastric Cancer?
Kim EY; Lee JW; Yoo HM; Park CH; Song KY
Ann Surg Oncol; 2015 Dec; 22(13):4363-70. PubMed ID: 25805235
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio.
Ferroni P; Riondino S; Formica V; Cereda V; Tosetto L; La Farina F; Valente MG; Vergati M; Guadagni F; Roselli M
Int J Cancer; 2015 Mar; 136(5):1234-40. PubMed ID: 25042739
[TBL] [Abstract][Full Text] [Related]
15. Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer.
Cong R; Kong F; Ma J; Li Q; Wu Q; Ma X
BMC Cancer; 2020 May; 20(1):464. PubMed ID: 32448185
[TBL] [Abstract][Full Text] [Related]
16. Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection.
Stotz M; Liegl-Atzwanger B; Posch F; Mrsic E; Thalhammer M; Stojakovic T; Bezan A; Pichler M; Gerger A; Szkandera J
PLoS One; 2016; 11(7):e0159448. PubMed ID: 27454486
[TBL] [Abstract][Full Text] [Related]
17. Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer.
Lian L; Xia YY; Zhou C; Shen XM; Li XL; Han SG; Zheng Y; Mao ZQ; Gong FR; Wu MY; Chen K; Tao M; Li W
Cancer Biomark; 2015; 15(6):899-907. PubMed ID: 26444485
[TBL] [Abstract][Full Text] [Related]
18. Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival.
Cummings M; Merone L; Keeble C; Burland L; Grzelinski M; Sutton K; Begum N; Thacoor A; Green B; Sarveswaran J; Hutson R; Orsi NM
Br J Cancer; 2015 Jul; 113(2):311-20. PubMed ID: 26079303
[TBL] [Abstract][Full Text] [Related]
19. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
[TBL] [Abstract][Full Text] [Related]
20. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.
Toyokawa T; Kubo N; Tamura T; Sakurai K; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M
BMC Cancer; 2016 Sep; 16(1):722. PubMed ID: 27599460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]